SE8301073L - Nya glykoproteiner, forfaranden for framstellning derav och terapeutiska medel innehallande desamma - Google Patents

Nya glykoproteiner, forfaranden for framstellning derav och terapeutiska medel innehallande desamma

Info

Publication number
SE8301073L
SE8301073L SE8301073A SE8301073A SE8301073L SE 8301073 L SE8301073 L SE 8301073L SE 8301073 A SE8301073 A SE 8301073A SE 8301073 A SE8301073 A SE 8301073A SE 8301073 L SE8301073 L SE 8301073L
Authority
SE
Sweden
Prior art keywords
sulfuric acid
reaction
exhibits
acid reaction
color indicating
Prior art date
Application number
SE8301073A
Other languages
English (en)
Swedish (sv)
Other versions
SE8301073D0 (sv
Inventor
H Ohnishi
K Yamaguchi
Y Suzuki
E Mochida
N Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8301073D0 publication Critical patent/SE8301073D0/xx
Publication of SE8301073L publication Critical patent/SE8301073L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8301073A 1982-02-26 1983-02-25 Nya glykoproteiner, forfaranden for framstellning derav och terapeutiska medel innehallande desamma SE8301073L (sv)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (2)

Publication Number Publication Date
SE8301073D0 SE8301073D0 (sv) 1983-02-25
SE8301073L true SE8301073L (sv) 1983-08-27

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301073A SE8301073L (sv) 1982-02-26 1983-02-25 Nya glykoproteiner, forfaranden for framstellning derav och terapeutiska medel innehallande desamma

Country Status (17)

Country Link
US (1) US4481137A (da)
BE (1) BE896027A (da)
BR (1) BR8300933A (da)
DD (1) DD209634A5 (da)
DE (1) DE3306297A1 (da)
DK (1) DK93383A (da)
FI (1) FI830638L (da)
FR (1) FR2522267A1 (da)
GB (1) GB2117385B (da)
GR (1) GR78097B (da)
LU (1) LU84662A1 (da)
NL (1) NL8300727A (da)
NO (1) NO830669L (da)
PL (1) PL240784A1 (da)
PT (1) PT76296B (da)
RO (1) RO85901B (da)
SE (1) SE8301073L (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインｉｉｉとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
EP0378676A4 (en) * 1988-07-15 1991-01-16 The Trustees Of Columbia University In The City Of New York Tumor necrosis enhancing factor and methods of preparation and use
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) * 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
RU2136695C1 (ru) * 1998-03-18 1999-09-10 ЗАОПП "Эндо-Фарм-А" Сывороточный гликопротеин, обладающий биологической активностью в сверхмалых дозах
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
ES2661168T3 (es) * 2003-07-12 2018-03-27 Accelerate Diagnostics, Inc. Biodetección sensible y rápida
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
US9434937B2 (en) 2011-03-07 2016-09-06 Accelerate Diagnostics, Inc. Rapid cell purification systems
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10023895B2 (en) 2015-03-30 2018-07-17 Accelerate Diagnostics, Inc. Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
BR8300933A (pt) 1983-11-16
RO85901A (ro) 1985-01-24
FI830638A7 (fi) 1983-08-27
GB2117385B (en) 1985-05-09
GB8305330D0 (en) 1983-03-30
PL240784A1 (en) 1983-11-07
PT76296A (en) 1983-03-01
GR78097B (da) 1984-09-26
NL8300727A (nl) 1983-09-16
BE896027A (fr) 1983-08-25
US4481137A (en) 1984-11-06
DK93383A (da) 1983-08-27
DD209634A5 (de) 1984-05-16
FI830638L (fi) 1983-08-27
FR2522267A1 (fr) 1983-09-02
PT76296B (en) 1985-11-12
NO830669L (no) 1983-08-29
FI830638A0 (fi) 1983-02-25
SE8301073D0 (sv) 1983-02-25
DK93383D0 (da) 1983-02-25
GB2117385A (en) 1983-10-12
LU84662A1 (fr) 1983-09-08
RO85901B (ro) 1985-01-30
DE3306297A1 (de) 1983-09-15

Similar Documents

Publication Publication Date Title
SE8301073L (sv) Nya glykoproteiner, forfaranden for framstellning derav och terapeutiska medel innehallande desamma
Frieden Biochemical adaptation and anuran metamorphosis
US3822348A (en) Hormone-like substance having serum calcium reducing property
US4619989A (en) Bone morphogenetic protein composition
US4761471A (en) Bone morphogenetic protein composition
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
AU571225B2 (en) Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a
ES8609365A1 (es) Un factor estimulante de colonias (csf)
BR112021010201A2 (pt) Peptídeos de colágeno produzidos de forma sintética e recombinante com eficácia biológica
KR870000924A (ko) 성장 호르몬 투여용 조절방출삽입자의 제조방법
Schofield et al. Procollagen-a precursor form of collagen
DE3264108D1 (en) Protein pp16, process for concentrating and isolating it, and its use
SU1012786A3 (ru) Способ получени протеинового комплекса,стимулирующего секрецию инсулина
Hoagland et al. Amino acid composition of αs3-, αs4-, and αs5-caseins
KR840002657A (ko) 인터페론 조성물의 제조방법
Vesely et al. Pea phytohemagglutinin selective agglutination of tumour cells
WO1994005702A1 (en) Extraction of collagen
Glimcher et al. The solubilization of collagen and protein–polysaccharides from the developing cartilage of lathyrytic chicks
JP2863898B2 (ja) 新規なペプチドおよび免疫賦活剤
JP2759457B2 (ja) 抗腫瘍性蛋白質
JP2002080340A (ja) 美容組成物
ES8500323A1 (es) Un procedimiento para obtener una glicoproteina (cb) que tiene un efecto anti-tumoral.
US20090227488A1 (en) Class of bioactive glycoprotein
JP2873434B2 (ja) 新規なペプチドおよび免疫賦活剤
JPH0534340B2 (da)

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8301073-6